DJ IDEXX Laboratories Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of IDEXX Laboratories Inc. $(IDXX)$ shed 1.38% to $457.35 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.27% to 6,051.97 and Dow Jones Industrial Average falling 0.50% to 44,368.56.
This was the stock's second consecutive day of losses.
IDEXX Laboratories Inc. closed 21.60% short of its 52-week high of $583.39, which the company reached on March 1st.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.56% to $155.26, Medtronic PLC $(MDT)$ rose 0.16% to $91.35, and Boston Scientific Corp. $(BSX)$ fell 0.20% to $105.77.
Trading volume (594,116) remained 59,365 below its 50-day average volume of 653,481.
Data source: Dow Jones Market Data, FactSet. Data compiled February 12, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 12, 2025 16:55 ET (21:55 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。